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 Third-degree burn wound is characterized by the full-thickness injury of 
the skin, including both the epidermal and the dermal layer. These wounds do not 
heal spontaneously and require excision of the necrotic tissue. Currently, split-
thickness skin autografts are commonly used for wound closure, but these can 
leave thick scars and distorted contractures, which is unfavorable both 
functionally and aesthetically. In previous works, we have developed a dextran-
based hydrogel that is chemically modified with allyl isocycanate and 
bromoethylamine (Dex-AE) that was tailored to enhance biocompatibility and 
host-cell infiltration in vivo. Polyethyl glycol diacrylate (PEGDA) was added to 
the hydrogel mix to strengthen the mechanical properties of the hydrogel without 
compromising the crosslinking density. The therapeutic effect of the gel was first 
confirmed by the murine in vivo burn wound model, where the hydrogel-treated 
wounds healed completely with regenerated skin appendages by week 8. We then 
aimed to translate this model into a porcine model because of its structural and 
biological similarities to the human skin. We first optimized our protocol to create 
third-degree burn wounds by using different contact temperature and duration. 
We used this established protocol to conduct our hydrogel treatment studies, 
where the burned necrotic wounds were first excised and then replaced with our 
Dex-AE/PEGDA hydrogels. The hydrogel degraded within 5 days after the 
implantation with higher cell infiltration compared to the control group.  In order 
to analyze the healing process, we have conducted histological assays as well as 
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blood flow analysis with a speckle contrast imager. Our preliminary data showed 
signs of higher blood support in the hydrogel-treated wounds that may have 
contributed to the better epithelial healing that we observed in treated group. We 
also observed higher cellular infiltration in the areas of the hydrogel-treated 
wounds compared to the untreated wounds, confirmed by the hematoxylin and 
eosin staining of the samples at day 2. With additional surgical adjustments, the 
bioactive hydrogel shows potential for delivering appropriate treatment for third-
degree burn wound healing. 
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 Burns are a leading cause of accidental death that can result in serious disability 
and social impairment from disfigurement [1]. In 2013, approximately 450,000 burn 
injuries received medical treatment [2].  Although the survival rate for burn injuries in 
general is high, certain categories of burn wounds have higher mortality rates than others. 
Of these categories, third-degree burn wounds presents the toughest challenge in the 
clinics. This type of wound is characterized by the full-thickness damage of the skin, 
including both the epidermal and the dermal layer. Unlike superficial burn wounds that 
most likely heal on their own without any professional care, third-degree burn wounds do 
not heal spontaneously and require excision of the necrotic tissue as well as replacement 
of the wounds with skin substitutes [3].  
 Wound healing is generally divided into three overlapping phases: inflammation, 
proliferation, and maturation/remodeling. In the inflammation phase, the transudate is 
leaked into the interstitial space, where platelets aggregate and form a plug with fibrin 
[4]. Inflammatory response is characterized by early polymorphonuclear neutrophil 
infiltration followed by monocyte and macrophage migration [4]. In humans, granulation 
tissue is formed during the proliferation phase, which occurs within 48 hours of injury 
[4]. Granulation tissue is a temporarily vascularized connective tissue that is formed by 
migrating fibroblasts [5]. In this phase, actin-rich myofibroblasts facilitate wound closure 
by pulling the wound margins together, resulting in wound contraction [4]. Keratinoytes 
from the epithelium also migrates into the wound to re-epithelialize the wound [4]. 
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Throughout the healing process, Type III collagen is replaced by mature Type I collagen, 
but the complete remodeling may continue up to 2 years where most amount of change 
occurs within the first 6 months [4]. However, scarring is inevitable, where the healed 
tissue can only regain a fraction of the original tissue strength and elasticity [5].    
 Angiogenesis plays an important role during the proliferative phase of wound 
healing. During this phase, the vessel capillary sprouts first digest and penetrate the 
basement membrane and invade the fibrin-rich wound plug to assist migration of other 
cell types such as fibroblasts and vascularize the granulation tissue [4]. The low oxygen 
tension in the wounded area creates a hypoxic environment that triggers the vascular 
endothelial growth factor (VEGF) signaling pathway [6]. Epidermis has shown to 
produce this factor in large quantities during wound healing to induce angiogenesis, and 
prolonged angiogenic stimulus by VEGF along with initial stimulus by basic fibroblast 
growth factor (bFGF) is critical for the neovascularization of the granulation tissue [7, 8]. 
Existing inflammatory cells at the provisional matrix provide angiogenic cytokines and 
growth factors as well to facilitate angiogenesis. Transmembrane cell-attachment protein 
αvβ3 has also shown to be essential. Of many integrin receptors that can bind to one or 
more extracellular matrix (ECM) domains, αvβ3 integrin is the only receptor that 
recognizes fibrin, fibronectin, and vitronectin, which are the characteristic components of 
a provisional matrix at the wound site [6]. During the invasion of capillaries into the 
provisional matrix, αvβ3 is highly expressed on the migrating vessels, especially at the tips 
[9]. As the wound ECM composition transitions from fibrin/fibronectin to mature 
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collagen, most of the new vessels degenerate through apoptosis, and the remaining blood 
vessels no longer express αvβ3 [6]. 
 Some of the characteristics of ideal skin substitute include (i) low cost, (ii) off-
the-shelf access, (iii) high flexibility, and (iv) fast vascularization [3]. Split-thickness skin 
autograft is the current gold standard for wound closure, but it can leave thick scars and 
distorted contractures, which is unfavorable both functionally and aesthetically. A few 
synthetic substitutes have made their ways to the market, but most provide only a 
temporary barrier until autografts are available for permanent closure [10]. Many studies 
are currently focusing on developing skin substitutes using cells, but there are too many 
hurdles for these products to go through before reaching the consumer due to strict 
government restrictions on biological products.  
 Porcine model has been favored over other animal models for skin wound studies. 
First, the skin of the pig most closely resembles human skin both anatomically and 
physiologically. Both have similar dermal-epidermal thickness ratio and dermal 
vascularization pattern [11, 12]. Biochemically, pig and human skins have similar 
collagen matrix and keratinous proteins [1]. Studies have also shown an excellent 
agreement between pig and human with respect to wound healing responses from growth 
factors such as epidermal growth factor (EGF) and bFGF [12]. In addition, the size of the 
animal allows control and comparison of different treatment parameters in the same 
animal, although the total area of wounds often is limited to 10% of the total body surface 
area. Despite the benefits, not many studies can afford pig model due to its high cost from 
maintenance, additional personnel, and general drugs administered during the experiment 
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[1]. In addition, there has been no study that establishes detailed, reproducible burn 
treatment procedures and wound healing evaluation criteria for large animal models, 
which further discourages porcine animal studies. 
Hydrogels are hydrophilic polymeric networks that are commonly used for 
creating 3D in vitro models of tissues, along with other types of scaffolds, microfluidic 
devices, and bioreactors. Hydrogels provide means of tuning the mechanical strength and 
chemical structures of the cellular microenvironment. Studies have shown that different 
stiffness of gels created by varying crosslinking densities can effect the proliferation, 
survival, and migration of the embedded cells and can also cue differentiation of stem 
cells to specific lineages [13-15]. In addition, hydrogels can be chemically modified to 
present cell-attaching sites (such as RGD amino acid sequence) and matrix 
metalloproteinase (MMP)-degradable sites which is crucial for tumor progression, 
endothelial migration, and, ultimately, tumor angiogenesis [15-18]. Over the last few 
years, our lab has focused on a few design parameters and developed a dextran-based 
hydrogel called dextran-allyl isocyanate-ethylamine (Dex-AE) that is tailored to promote 
rapid formation of new functional blood vessels (functional neovascularization) for in 
vivo murine model [19, 20]. The amine groups incorporated in these hydrogels enhance 
the biocompatibility and integration with the host tissue. In addition, low crosslinking 
density allows high flexibility of the structure as well as fast infiltration by host cells. 
Treatment with Dex-AE hydrogel on murine burn wounds with no additional drugs or 
cells has shown to promote complete skin regeneration with dermal appendages (glands, 




 The first goal of this study is to synthesize and characterize the new batches of 
Dex-AE synthesized to be used for the rest of the study. In addition, we establish surgical 
protocol for creating third-degree burn wounds on a pig. After we confirm the therapeutic 
effects of the hydrogel from preliminary in vivo murine experiment, the newly 
synthesized Dex-AE is to be used to investigate its therapeutic effect on a porcine model 
for third-degree burn wound healing.  
Overall Approach 
 First, newly synthesized Dex-AE is characterized by its mechanical, chemical, 
and therapeutic properties using swelling analysis, proton nuclear magnetic resonance 
(HNMR) spectroscopy, and murine burn in vivo model. Then, optimal temperature and 
duration of the contact burn was established to create third-degree burn wounds on a pig. 
The third-degree damage was confirmed by hematoxylin & eosin (H&E) and Masson’s 
Trichrome staining of the wound histological sections. The wounds created using this 
protocol was then treated with Dex-AE hydrogels by first excising the necrotic tissue and 
replacing the excised wound with crosslinked Dex-AE hydrogel (figure 1). The healing 
progress was monitored and evaluated by histological analysis of neovascularization and 
re-epithelialization, blood flow measurements, quantitative polymerase chain reaction 




Figure 1. Overall approach. Dex-AE and PEGDA is first crosslinked to form a hydrogel. The burned 
necrotic tissue is excised and replaced with the crosslinked hydrogel for treatment [21]. 
Experimental Methods 
Materials 
Dextran (Dex, MW=70,000), allyl isocyanate (AI), anhydrous dimethyl sulfoxide 
(DMSO), dibutyltin dilaurate (DBTDL), 2-bromoethylamine hydrobromide (BEAHB), 
triethylamine (TEA), acryloyl chloride, polyethylene glycol (MW=4,000), deuterium 
oxide, and other chemicals were purchased from Sigma-Aldrich (St. Louis, MO). Dextran 
was dried in 60°C overnight before reaction. The photoinitiator Irgacure® 2959 (1-[4-(2-
hydroxyethocy)-phenyl]-2-hydroxy-2-methyl-1-propane-1-one) was purchased from 
BASF Corporation (Florham Park, NJ). Dialysis membrane (MW cut off = 1,000 Da) 
was purchased from Spectrum Labs, Inc. Male 8-week-old 129S1/SvImJ mice was 
purchased from The Jackson Laboratory. Yorkshire pigs (~50lb) were purchased from a 
single breeding farm and were housed and maintained at Thomas D. Morris, Inc. 
(Reisterstown, MD).  
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Dextran-Allyl Isocyanate-Ethylamine (Dex-AE) Synthesis 
 The chemical modification of dextran polymers involved two steps (figure 2). 
First step was the incorporation of AI into dextran. Pre-dried dextran (e.g. 2g) was first 
dissolved in anhydrous DMSO (20mL) at room temperature under nitrogen gas. Reaction 
catalyst DBTDL was added (0.210mL), and AI (0.240 mL) was added to the solution 
dropwise. The reaction was run for 6 hours in 35°C. After the reaction, the solution was 
precipitated in cold excess isopropanol and filtered. The resulting Dex-AI was then 
dialysized against distilled water for 3 days and lyophilized for additional 3 days. The 
purified polymer was stored in vacuum until further use.  
 The second part of the reaction was the substitution of the remaining hydroxyl 
groups in Dex-AI with ethylamine groups. For this step, pre-dried Dex-AI (e.g. 2g) was 
first dissolved in DMSO (30ml) under nitrogen gas. Meanwhile, BEAHB (3.75g) was 
dissolved in DMSO (10ml) in a separate chamber. Catalyst TEA (11.2mL) was added to 
the Dex-AI DMSO solution, and the dissolved BEAHB in DMSO was added to the 
solution dropwise. The reaction was run for 6 hours at 50°C. After the reaction, TEA salt 
was filtered and the resulting solution was precipitated in cold excess isopropanol and 
filtered. The resulting Dex-AE was then dialysized against distilled water for 3 days and 
lyophilized for additional 3 days. The purified polymer was stored in vacuum until 




Polyethylene Glycol Diacrylate (PEGDA) Synthesis 
 PEGDA was synthesized according to previously established method [22]. 
Briefly, pre-dried PEG (e.g. 8 g) was dissolved in anhydrous benzene under nitrogen gas 
at 40°C. After complete dissolution, the temperature was cooled down to the room 
temperature, and TEA (1.19mL) was added. Acryloyl chloride (0.81mL) was added 
dropwise. The reaction was run for 2 hours at room temperature and then increased to 
80°C for an additional hour. TEA salt was filtered after the reaction, and the resulting 
solution was precipitated in cold excess hexane and filtered. The PEGDA was then 
dialysized against distilled water for 3 days and lyophilized for additional 3 days. The 
purified polymer was stored in 4°C until further use.  
Preparation of Dex-AE/PEGDA Hydrogel 
 We dissolved Dex-AE and PEGDA at the weight ratio of 80:20 into phosphate-
buffered saline containing 0.1% (w/w) Irgacure® 2959. The mixture was pipetted into a 
sterile mold made by polydimethylsiloxane (8mm in diameter by 2mm in thickness) and 
photocrosslinked (10mW/cm2 of UV light for 10 minutes).  
Swelling analysis 
 The prepared hydrogels were first swollen in distilled water overnight to remove 
uncrosslinked macromers from the hydrogel. The hydrogels were then dried overnight 
and the dried weights were measured. The hydrogels were swollen in distilled water, and 
at specific time points, the wet weights of the hydrogels were measured after the residual 
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where Ws,t is the weight of the swollen hydrogel at time t, and Wd is the dry weight of the 
hydrogel. 
Chemical structure analysis 
 The newly synthesized Dex-AE polymers were dissolved in deuterium oxide at 
10mg/mL concentration. 1HNMR spectroscopy was performed using AMX-300 NMR 
spectrometer (Bruker) at 300MHz frequency. The reference peak was set at 4.8ppm. 
Murine surgery procedure 
 Surgical procedures were approved by the Johns Hopkins University Animal Care 
and Use Committee and are reported previously in detail [21, 23]. Briefly, the burn injury 
was created with a 220g aluminum rod (1.2cm diameter) heated in a 100°C water bath for 
5 min. The wounds were created on the posterior-dorsum of each mouse for 4 seconds. 
The necrotic skin was removed full-thickness with an 8mm diameter biopsy punch. The 
wounds were then treated with the hydrogels and covered with DuoDerm dressing 
(ConvaTec Co.).  
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Porcine surgery procedure 
 Surgical procedures were approved by the Institutional Animal Care and Use 
Committee at Thomas D. Morris, Inc. prior to the experiments. All pigs were fasted for at 
least 12 hours prior to any surgical procedure. Anasthesia was induced by an 
intramuscular injection of Telazol  cocktail reconstituted with ketamine and xylazine. 
Then, the pig was endotracheally intubated and ventilated mechanically to aid breathing 
and to provide up to 1.5% of isoflurane (depending on the painfulness of the procedure) 
to maintain anasthesia. In addition, blood pressure, heart rate, body temperature, and 
blood oxygen level was monitored. Bair Hugger® was placed under the pig and set to 
43°C to maintain a normal body temperature.  
 Thoracic paravertebral zone was chosen as the burn site to minimize the trauma 
resulting from pig’s movement or lying. Before creating the wounds, the hair at the burn 
site was removed with a razor blade followed by the sterilization of the area with iodine.  
 Two parameters were optimized to establish third-degree burn wound protocol via 
a separate live-pig study: duration of the contact burn and the temperature of the metal 
bar. The metal bar was first heated using a heating plate (Fisher Scientific, Inc.) to 100°C 
or 200°C, monitored with the thermometer. The device was aligned perpendicular to the 
skin’s surface and applied for 15, 30, or 60 seconds at a constant pressure of 2kg/cm2. 
Histological sections were obtained at day 1 and day 2 to assess the degree of burn 
damage. 
  Two pigs were used to investigate the therapeutic effect of Dex-AE hydrogel on 
burn wounds. The wounds were left alone for 48 hours for stabilization before the 
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excision procedure. In the first pig, a total of 22 circular third-degree burn wounds 
(1.5cm in diameter) were created. A circular biopsy punch with a diameter of 1.2cm was 
used to excise out the full-thickness wound down to the necrotic adipose layer. Peripheral 
wound was left unexcised to simulate a clinical practice [20]. In the second pig, a total of 
20 burns wounds were created (4 bigger square wounds with sides of 3cm, 16 smaller 
circular wounds with diameters of 1.5cm). Wounds were at least 3cm apart from one 
another to minimize hindered wound healing process due to one another. Bigger wounds 
were excised to completely remove the necrotic tissue, and the smaller wounds were 
excised the same way as the first pig.  
 After the excision procedure, wounds were cleaned with sterile gauze to 
temporarily stop bleeding. Half of the wounds were treated with Dex-AE hydrogel and 
the other half were left untreated. Hydrogels were crosslinked with sizes that matched the 
size of the excised wounds. Treated and untreated wounds were first sealed with 
Tegaderm® (3M). The peripheries of the wound site was applied with compound benzoin 
tincture (Medical Chemical, Corp) to enhance the Tegaderm® adherence to the skin. 
VetRap® (3M) was wrapped around the dorsal and the ventral areas to keep the first layer 
in place. Finally, a body suit (VetMedCare) was worn over the body. After the hydrogel 
was degraded, all wounds were placed with a non-adhesive, non-absorptive dressing 
CurityTM (Covidian) to prevent epidermal damage when removing Tegaderm® (figure 2).   
 Dressings were changed three times a week until wound closure was complete. 
Before the dress change, the pig was put under anesthesia with an intramuscular injection 
of Telazol  cocktail reconstituted with ketamine and xylazine. The pig did not receive 
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isoflurane because the procedure was quick. Before reapplying dressings, the wound area 
was scrubbed with 4% chlorhexidine and ethanol. The area was wiped with dry gauze 
and new dressings were applied.  
 
Figure 2. Dressing procedure. (a) Burn was first created on the pig on the thoracic paravertebral zone. 
After the excision, the treated group received hydrogels inside the excised area and the non-treated group 
wounds were left excised. (b) The peripheries of the thoracic paravertebral zone were coated with benzoin, 
and the wounds were dressed with Tegaderm®. (c) The subject was then wrapped with VetRap®. (d) A 
body suit was put over the body. 
 
 To evaluate healing, skin specimens were biopsied at each time point as complete 
horizontal cross-sections of approximately 5cm in thickness with a sterile blade.  
 Analgesics was administered before wound creating and biopsy procedures, and 
transdermal fentanyl patch was applied for 9 days post-operation.  
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 Blood test was performed regularly to monitor the pig’s health throughout the 
study. 
Evaluation of Wound Healing 
During the study, the blood flow inside the wounds were monitored noninvasively 
using moorFLPI speckle contrast imager (Moor Instruments, Inc.). The measurement was 
normalized by the blood flow measurement of the healthy skin area adjacent to each 
wound. 
For immunohistochemical assay, collected skin specimens were first fixed with 
10% formalin (Fisher Scientific, Inc.) for at least 48 hours. Following fixation, samples 
were dehydrated in graded ethanol (70% to 100%), embedded in paraffin, sectioned at 5 
μm, and stained with either H&E or immunohistochemistry for CD31 (Abcam, Dako), α-
SMA (Dako), cytokeratin 14 (Abcam), and Masson’s trichrome.  
The area and number of vessels inside the wounds were quantified using ImageJ 
software (National Institutes of Health) with histology sample of each wound stained 
with CD31. The vessels were imaged at the edges, middle, and top portions of each 
wound, and the positively stained areas were selected using the software’s threshold 
function. The selected areas were then quantified using “Analyze Particles” plugin of 
ImageJ. “Vessels” with areas less than 78μm2 were excluded to filter out noise.  
  Epithelial thickness was visualized with the immunohistochemical staining of 
cytokeratine 14 and was quantified using ImageJ. For each wound, at least 12 thickness 
measurements were made and averaged to calculate the average distance between the 
surface and the basement membrane of the epithelium.  
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 Two-step reverse transcription polymerase chain reaction (qPCR) was performed 
on wound specimens in accordance with Applied Biosystems manufacturer instructions 
[24]. To extract RNA, a small specimen was collected from each wound at different time 
points and snap-frozen in liquid nitrogen. The specimen was crushed with pestle and 
mortar, and the powdered sample was put in 1mL of Trizol reagent and stored in -80°C 
until further use. Wound healing PCR array sets were purchased from Qiagen to compare 
the expression profile inside the treated and non-treated wounds at different time points. 
For each primer, the comparative computerized method provided by Qiagen was used to 
calculate the amplification differences between different samples.  
Statistical analysis 
 Statistical analysis was performed with either one-way ANOVA with Tukey’s 
post tests or two-way ANOVA with Bonferroni post tests where appropriate using 
GraphPad Prism® 6. Significance levels between the non-treated wounds and treated 
wounds were set at: *p < 0.05, **p < 0.01, and ***p < 0.001.  
 Two wounds per condition were created on a porcine cadaver for optimizing the 
surgical procedure to create 3rd degree burn wounds. For the subsequent hydrogel studies, 




Dex-AE /PEGDA Hydrogel Preparation 
 Dextran was first functionalized with acrylate group to facilitate crosslinking 
reaction via photocrosslinking reaction under a long wave ultraviolet lamp. The overall 
schematics of the reaction is shown in figure 3. During the reaction, a fraction of 
hydroxyl group reacts with the isocyanate (NCO-) group of AI via nucleophilic attack, 
resulting in urethane bonds. 1HNMR spectroscopy revealed the degree of substitution of 
AI to be 0.25 (figure 4). The hydroxyl groups in Dex-AI that have not been 
functionalized with AI were reacted with BEAHB. Amine group is a weak base that 
readily ionize, and even when not ionized, the high electronegativity of nitrogen result in 
partial charge that make it highly hydrophilic. In addition, amine-functionalization in 
hydrogels has shown to enhance biocompatibility and drug release profile [19]. 1HNMR 




Figure 3. Chemical modification of Dex-AE. The hydroxyl groups in dextran were first modified with AI 
and further modified with BEAHB to form Dex-AE. 
 
 





 Although low DS value of acrylate group allows low crosslinking density and 
high hydrogel pore size that facilitates host cell infiltration, Dex-AE hydrogel is unstable 
and does not have enough structural durability to retain a three-dimensional shape. 
PEGDA was added to the polymer mix to provide mechanical strength. Previous study 
has shown that mixing Dex-AE with PEGDA in the ratio of 80/20 allows mechanically 
durable hydrogel (elastic modulus of ~1kPa) without compromising the loose interior 
architecture [20]. PEG is not biodegradable, but low molecular weight PEG polymers are 
readily excreted from the body are already approved by the FDA for medical uses. 
extensively for a drug delivery, stem cell differentiation, and cell-patterning [25]. 
PEGDA is innately hydrophilic, and the Dex-AE/PEGDA hydrogel is able to retain water 
up to 3,500% of its dry weight (figure 6). This makes the hydrogel a great candidate for 
skin scaffold since the ability to maintain hydration is critical for the healing of burn 
wounds [4].  
 
Figure 5. Swelling kinetics of Dex-AE/PEGDA hydrogel.  
 






















Treatment of burn wounds with Dex-AE/PEGDA hydrogels on mice 
 In order to investigate the therapeutic effect of Dex-AE/PEGDA hydrogel on burn 
wounds, necrotic burn wounds were excised and treated with the hydrogels for 8 weeks. 
H&E staining of week 3 biopsy samples of treated wounds showed complete re-
epithelialization of the wounds (figure 7a). Complex structures that resemble skin 
appendages were also observed at week 3, and by week 8, skin was fully healed with hair 
growth (figure 7b). Previous report has shown high inflammatory and angiogenic cell 
infiltration in hydrogel-treated wounds, expediting and aiding the wound healing process 
[21].  
 
Figure 6. Treatement of murine burn wounds with Dex-AE/PEGDA hydrogel. (a) H&E staining of 
wound samples from two different hydrogel batches at day 7. Arrow shows the formation of glands. W = 
healing wound, H = healthy skin. (Bar = 500μm) (b) Macroscopic view of the healing wounds treated with 




Creation of third-degree burn wounds on pigs 
 Pig is a great model for wound healing studies for the reasons explained in the 
introduction. However, an appropriate protocol for creating burn wounds in a third-
degree level must first be established. Figure 7 shows the custom-made device for 
creating burn wounds [26]. The device is comprised of three parts. The metal rod part is 
made of stainless steel which is used for contact burn once it is heated up. The middle 
part is an insulating unit made of polytetrafluoroethylene for holding the device upright 
for the duration of the burn. The syringe part provides a spring force from the trapped air, 
which can be kept consistent for all wounds by applying the same amount of pressure 
using the side measurement marks. The metal rod part was designed to be exchangeable 
to be able to minimize the time needed to heat the metal by using multiple rods. In 
addition, each rod was drilled with a small hole to monitor its core temperature with a 
digital thermometer (ThermoFisher Scientific, Inc.). Two critical parameters for burn 
wounds are temperature of the burning object and the duration of the contact with the 
object [5]. Pressure can also affect the degree of the burn damage, but not as much as 
temperature and the duration [27]. Therefore, an appropriate value of pressure was simply 




Figure 7. Burn wound device. The stainless steel unit was custom-made to create the desired wound size. 
The syringe part provides a measureable and controllable compressive force when creating the burn. The 
insulating unit was placed to hold the device in the upright. 
 
 The degree of burn damage was evaluated by H&E and Masson’s Trichrome 
stains of wounds 24 hours or 48 hours after the burn (figure 8). Tissue damage from burn 
is characterized by (1) purple H&E staining of the area and (2) red Trichrome staining of 
the area which represents damaged collagen [26, 28]. Of all the parameters we tested, 
damage in collagen was only observed in wounds burned at 200°C. In addition, the 
damage seemed to progress between 24h and 48h for this temperature. For significant 
burn damages, a progression of burn depth can be found until 48h post-injury compared 
to superficial damages [29]. For duration, both 30 seconds and 60 seconds at 200°C 
yielded wounds with third-degree damages after 48 hours, but 30 second contact yielded 
more consistent results compared to 60 seconds with less error. In addition, 60 second 
contact with the heated object created a much bigger wound compared to 30 second 
contact due to the longer exposure to the peripheral heat from the stainless steel rod. 
Therefore, optimal parameters (200°C for 30 seconds) were chosen and used for the rest 




Figure 8. Extent of burn injury of porcine skin using different contact temperature and duration. 
 
Treatment of burn wounds with Dex-AE/PEGDA hydrogels on pigs 
 In the first hydrogel study, we created a total of 22 third degree burns with 1.2cm 
diameter stainless steel device (Figure 9). The resulting wounds were bigger than the 
diameter of the heated device (about 1.5cm diameter) due to the damage from the 
peripheral heat. A biopsy punch with a diameter of 1.2cm was used to excise out the 
wound, leaving out some peripherally damaged tissue to simulate a method practiced on 
humans in some clinics [21]. Figure 10 shows the histological staining of CD31 and α-
SMA from the first hydrogel study. CD31 is a characteristic marker for blood vessel 
endothelial cells. α-SMA stains the smooth muscle actins found in smooth muscle cells 
that surrounds blood vessels as well as those found in myofibroblasts that are responsible 
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for the contraction of the wounds. Most myofibroblasts were found at the edges for both 
treated and non-treated group. However, we observed much stronger myofibroblast stains 
for non-treated group compared to the treated group. Quantification of vessels stained 
with CD31 showed similar average vessel area and vessel density for both non-treated 
and treated groups except for the top part of the wound for week 1 (figure 11a). On week 
1, the vessels grown in the hydrogel treated wound were significantly larger than those in 
the non-treated wounds. The quantification generally agrees with the blood flow 
measurements taken with the speckle contrast imager, although the histological analysis 
was done less frequently compared to blood flow measurements, resulting in missing the 
time point when the blood flow hit the maximum (figure 11b). Overall, both non-treated 
and treated group showed a pattern of increasing blood flow in the early time points (day 
0 to day 12) followed by regression.  
 
Figure 9. Wound schematic of the first porcine hydrogel treatment study. Each wound was created 
with a 1.5 cm diameter, and after 48 hours, 1.2 cm diameter of the necrotic tissue was excised out, leaving a 




Figure 10. Vascular and myofibroblast characteristics in healing wounds. (a) CD31 staining of wounds 




Figure 11. Quantification of vascular characteristics of healing wounds. (a) Quantification of i) vessel 
density, ii) area % covered by the vessels, and iii) the average are of the vessels from the histological 
samples of healing wounds at days 7, 14, and 21. (b) Blood flow measurements from speckle contrast 
imager up to day 40. Day -2 is the time point when the burn wound was created.  
 
 Re-epithelialization was completed in about 14 days for both non-treated and 
treated wounds. Cytokeratin 14 (K14) stain of wound histology samples showed the 
thinning of the epithelium layer after the re-epithelialzation was completed (figure 12a). 
Treated wounds’ epithelium layers thinned to the thickness comparable to the healthy 





Figure 12. Epidermal characteristics of healing wounds. (a) K14 staining of healing epithelium at days 
7, 14, 21, and 40. (b) Quantification of epidermal thickness at days 14, 21, and 40. 
 
 The first pig was monitored for 40 days after the treatment of the wounds. Figure 
13 shows the macroscopic representation of the healing process for the treated and non-
treated wounds. Macroscopically, the treated and non-treated wounds did not look very 
different from one another.  
 
 
Figure 13. Macroscopic view of the healing wounds. 
 
 From the first hydrogel study, we learned that the hydrogel degraded completely 
within a week, and we needed to further characterize the wound kinetics within the first 
week of healing process at the histological level. In addition, not a lot of differences 
between the treated and the non-treated were observed, and we suspected that either the 
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peripheral burn wounds that were left out from being excised were screening the 
therapeutic properties of the hydrogel or the wounds were too small that body’s own 
spontaneous healing mechanism is good enough that the hydrogel did not help. With the 
second study, three issues were investigated: (1) the host-material interaction between 
Dex-AE/PEGDA hydrogel and the skin at earlier time points (< d7), (2) change in 
healing kinetics by the complete excision of burned necrotic tissue before hydrogel 
treatment, and (3) the therapeutic effect of the hydrogel on a bigger wound. In order to 
address this, we created 4 bigger wounds (3cm x 3cm) and 16 smaller wounds (same size 
as those in first hydrogel study). For the bigger wound, square shape was chosen to 
visualize contraction better and to be able to collect smaller circular biopsy samples (0.6 
cm diameter) at multiple time points from the same wound. Figure 14 shows the 
schematics of the wound for this second study. The smaller wounds were excised and 
treated the same way as they were in the first study, where some of the peripheral burn 
wound was not excised. The bigger wounds were completely excised including the 
peripheral burn wound. One bigger wound in each group was tattooed around the edges 
to monitor wound contraction throughout the study. The healing process was monitored 




Figure 14. Schematics of the wounds created on the second pig. Each smaller wound was 1.5 cm in 
diameter, and 1.2 cm of its necrotic tissue was excised out, leaving some peripheral wound at the rim. Each 
bigger wound was a 3 cm by 3 cm square, and all of its necrotic tissue was excised out. 
 
 
Dex-AE/PEGDA hydrogel is degraded by the host cells within five days after the 
hydrogel implantation. Hydrogel was observed in histological sample with some cellular 
ingrowth in day 2 (figure 15). However, No vessels were observed inside the wound yet. 
In day 5, newly formed vessels were observed at the edge, but had not yet reached the 
center of the wound (figure 16a). The quantification of vessels showed that at the edges, 
more area was covered by the vessels in the treated wounds compared to the non-treated 
wounds (figure 16b). This was also confirmed by the speckle contrast imager blood flow 
data at the edges (figure 16c). Macroscopically, the small wounds did not show 
significant differences between treated and untreated groups, similar to the first hydrogel 





Figure 15. H&E staining of healing wounds at day 2. Arrow heads point to hydrogel fragments that have 




Figure 16. Vascular characteristics of the healing wound at day 5. (a) CD31 staining of the wound 
histology sampels. (Bar = 500μm) (b) Quantification of vessel density and the area covered by the vessels 
at the edge of the healing wound at day 5. (c) Blood flow measurements of the wound edge areas at early 




Figure 17. Macroscopic view of the wound healing progression. (Bar = 5mm) 
 
 Full excision of the peripheral wounds seems to increase cell infiltration and 
enhance the host-material interaction. H&E staining of the wound edges at day 2 showed 
much more cells infiltrated inside the hydrogel compared to the non-treated wound 
(figure 18). In addition, there seems to be a difference between treated and non-treated 
wounds in on day 7 at the edges in terms of the area covered by the new vessels and the 
number of vessels per area, although more data is needed to check statistical significance 
(figure 19a&b). Speckle contrast imaging measurements of blood flow revealed slower 
healing kinetics of bigger wounds compared to the small wounds, evaluated by delayed 
regression of flow (figure 19c). In addition, a couple of spikes in blood flow were 
observed for wounds from both groups whenever the subject scratched its back and 




Figure 18. H&E staining of edges of bigger wounds (3cm x 3cm) at day 2. Arrow heads point to 





Figure 19. Vascular characteristics of healing bigger wounds (3cm x 3cm). (a) CD31 staining at the 
edges of the wounds. W = healing wound, H = healthy skin. (Bar = 500μm) (b) Quantification of the area 
covered by the vessels and the vessel density at the edges of the wounds. (c) Blood flow measurements 







Performing qPCR on day 14 large wound samples revealed key differences in 
gene expression profiles between treated and non-treated groups (Table 1).  Notably, 
almost three-fold higher expression of integrin subunit β3 (ITGB3) was observed in the 
treated wound compared to the non-treated wound. When dimerized with integrin subunit 
αv (ITGAV), integrin β3 aids in endothelial cell migration into the provisional matrix [6]. 
Almost two-fold higher expression was observed for MMP-9 in treated wound. MMP-9 
aids keratinocyte migration and granulation tissue remodeling [30, 31]. In contrast, 
MMP-3 expression was lower in treated wound by 0.5 fold. We also observed lower 
expression of inflammatory cytokines IL-1A and -1B and chemokine (C-C motif) ligand 
2 (CCL2) in treated wound by less than 0.5 fold. Heparin-binding epidermal growth 
factor (HPEGF), which is known to enhance stromal cell recruitment, re-epithelialization 













Table 1. Expression of key wound healing genes at the wounds at day 14. 
 
Macroscopically, wounds from both groups appeared similar in terms of 
discoloration and re-epithelialization (figure 20a). Quantification of the area also 
revealed similar contraction trend between the groups (figure 20b). In the earlier time 
points, the treated wound actually expanded, but started contracting at day 7 and 
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eventually caught up with the control group. The contraction was followed by wound 
expansion at later time points, possibly due to the subject’s general growth in body mass.  
 
Figure 20. Macroscopic view of healing wounds and contraction. (a) Macroscopic view of healing 




 In general, porcine model showed a different response to the Dex-AE/PEGDA 
hydrogel compared to the murine model. This could be due to the procedural difference 
or the physiological difference between the two models that were exploited. For example, 
the hydrogel was degraded almost completely by day 5, whereas in murine model, the 
complete degradation of the hydrogel took more than a week [21]. One possible 
explanation could be that the inflammatory cells in pigs infiltrate and degrade the gels 
much faster than those in mice. Fast degradation could also be due to possible bacterial 
infection in the early stage of the wound healing. The hydrogel degradation can be 
accelerated with the addition of bacteria since these cells are able to degrade dextran with 
a variety of endo- and exo-dextranases [34]. The dark discoloration of the wounds in days 
2 and 5 that seems like a necrotic tissue may also be due to the possible infection.  
 We observed higher blood flow and higher vessel coverage around the wound 
edges at day 5, but we could not observe further significant differences in the 
vascularization process between the two groups after that time point. We did however 
observe better thinning of the epithelial layer after the re-epithelialization and also 
observed bigger blood vessels near the epithelial layer at day 7. Better blood flow to the 
epithelium at the early time point could have contributed to better epithelial healing.  
 In terms of re-epithelialization, we learned that the pigs scratch their backs often 
during the first three weeks of treatment where the wounds were created. Sometimes this 
resulted in re-opening of the wounds, confirmed by increased blood flow measurement at 
these time points. There are ways to numb their backs and prevent them from scratching, 
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but these methods are invasive and may interfere with the healing process. The better 
way would be to use additional dressing above the wounds to minimize the physical 
damaging of the wounds by the scratching.  
 qPCR data at day 14 give interesting perspective on wound healing in terms of 
gene expression profiles, but more data at different time points are needed to observe the 
change in these profiles over time in order to make an informed conclusion.  
 Addition studies need to be conducted to optimize the treatment protocol, to 
strengthen statistical significance, and to investigate the effect of removing the peripheral 
wound on small wound healing. Removing the peripheral wound completely before the 
hydrogel treatment seems to enhance cellular infiltration of the hydrogel for the bigger 
wounds. This may enhance and expedite the healing process for the treated groups. We 
also need to repeat the big wound study with more time points for histological assessment 
to monitor the healing progress at the microscopic level. In addition, wound contraction 
data needs to be normalized by the pig’s body growth. This may be achieved by tattooing 
the area near the wound that does not contract with the wound and measure the increase 
in the body surface area.  
 There may be other ways to design the hydrogel to enhance the healing process. 
For example, cell attachment sites such as RGD amino acid sequence can be added to the 
hydrogel so the host cells can migrate into the hydrogel better. However, the hydrogel 
should be designed to be degraded slower so the attachment sites stay intact while the 
cells migrate. The hydrogel can also be loaded with growth factors such as VEGF and 
EGF, which may enhance the cellular response to the treatment. However, adding 
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biological factors is not practical since this would result in the hydrogel going through 
tougher FDA restrictions and delaying the use in clinical settings. Therefore, before 
changing the designs of the Dex-AE/PEGDA hydrogel, we need to perform additional 
experiments as described above to ascertain the therapeutic effects of the hydrogel. 
Conclusion 
 Preliminary data suggest a higher blood supply in the hydrogel-treated wounds 
that may have contributed to the better epithelial healing that we observed in the treated 
wounds. The Dex-AE/PEGDA hydrogels degrade within 5 days after their implantation, 
and more infiltrated cells were observed in the treated group with fully excised wounds 
compared to the treated group with partially excised wounds and non-treated group. More 
studies with wounds with full-excision need to be done in order to investigate the 
therapeutic effect of the hydrogel and understand the change in expression levels of 
wound healing genes over a longer period of time for both treated and non-treated 
groups. Moreover, additional studies involving bigger wounds need to be performed to 
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